Problemas psicológicos asociados al trasplante de órganos

International Journal of Clinical and Health Psychology 01/2005;
Source: DOAJ

ABSTRACT El trasplante de órganos es una alternativa terapéutica para aquellos pacientes que tienen problemas graves en el funcionamiento de un órgano vital: corazón, hígado, pulmón, etc. Dada la relevancia de este tema, en el presente estudio teórico analizamos los principales problemas psicológicos asociados al trasplante de órganos. Concretamente, hemos tenido en cuenta los siguientes apartados: 1) Repercusiones psicológicas del trasplante de órganos en los pacientes: delirium, trastornos sexuales, trastornos del estado de ánimo, trastornos de ansiedad, fantasías sobre el donante, insatisfacción con la imagen corporal y otros trastornos; 2) variables psicosociales que influyen en las repercusiones psicológicas asociadas al trasplante de órganos: apoyo familiar, trastornos psicológicos en los familiares, hospitalización, expectativas pre y post-trasplante, estrategias de afrontamiento, duración de la enfermedad, etiología del trasplante, procedencia del órgano implantado y otras variables; 3) fases psicológicas en los trasplantados renales, hepáticos y cardíacos en función de diferentes periodos temporales de comparación; 4) calidad de vida en los trasplantados y variables que la predicen: adherencia terapéutica, hospitalización, apoyo familiar, expectativas hacia el trasplante y etiología del trasplante; y 5) repercusiones psicológicas del trasplante de órganos en los familiares, teniendo en cuenta la influencia que ejerce el apoyo social sobre la salud mental de estos familiares.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background/Aim: The impact of liver disease and medical complications on quality of life (QOL) and psychological distress before and after orthotopic liver transplantation (OLT) is a matter of growing interest.Methods: Perceived QOL (LEIPAD Quality of Life test) and psychological distress (Brief Symptom Inventory, BSI) were assessed in 40 cirrhotic patients listed for OLT (Group A) and in 101 liver transplant recipients (Groups B to G=0–6, 7–12, 13–24, 25–36, 37–48, 49–60 months post-OLT). Patients were also evaluated for medical complications, blood levels of immunosuppressive agents and recurrence of liver disease.Results: QOL and psychological distress were significantly better in most of the post-OLT groups than in cirrhotic patients. Among post-OLT patients, a significantly worse QOL was perceived at 13–24 months (Life Satisfaction: Group D vs G, p=0.024; Cognitive Functioning: Group D vs F, p=0.024), while significantly greater psychological distress was detected at 7–12 months (Anxiety and Interpersonal Sensitivity: Group C vs Group B, p=0.032 and p=0.023, respectively). Medical complications and immunosuppressive therapy did not influence QOL or psychological distress after OLT. Within 6 months after OLT, patients with HCV recurrence showed significantly greater Depression (p=0.023), Anxiety (p=0.038), Phobic Anxiety (p=0.001), and Paranoid Ideation (p=0.033) than anti-HCV negative patients.Conclusions: Liver transplantation improves psychological distress and most, but not all, QOL domains. Recurrent HCV infection is associated with greater psychological distress.
    Journal of Hepatology 11/2000; · 10.40 Impact Factor
  • Transplantation Proceedings 12/2000; 32(7):2144-8. · 0.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although poor psychological adjustment to organ transplantation appears to be a major contributor to reduced quality of life and increased physical morbidity, the prevalence and risk factors for psychiatric disorder have not been considered beyond the first 12-18 months after transplantation. The authors enrolled a representative sample of 191 heart transplant recipients in a prospective examination of the prevalence, clinical characteristics, and risk factors for DSM-III-R major depressive disorder (MDD), generalized anxiety disorder (GAD), associated adjustment disorders, and posttraumatic stress disorder related to transplant (PTSD-T) during the 3 years postsurgery. Survival analysis indicates that cumulative risks for disorder onset were MDD, 25.5%; adjustment disorders, 20.8% (17.7% with anxious mood); PTSD-T, 17.0%; and any assessed disorder, 38.3%. There was only one case of GAD. PTSD-T onset was limited almost exclusively to the first year posttransplant. Episodes of MDD (but not anxiety disorders) that occurred later posttransplant (8 to 36 months postsurgery) were more likely than early posttransplant episodes to be treated with psychotropic medications. For both MDD and anxiety disorders, later episodes were less likely to be precipitated by transplant-related stressors than other life stressors. Factors increasing cumulative risk for psychiatric disorder posttransplant included pretransplant psychiatric history, female gender, longer hospitalization, more impaired physical functional status, and lower social supports from caregiver and family in the perioperative period. Risk factors' effects were additive; the presence of an increasing number of risk factors bore a dose-response relationship to cumulative risk of disorder.
    Psychosomatics 01/2001; 42(4):300-13. · 1.67 Impact Factor

Full-text (2 Sources)

Available from
Jan 8, 2015